Ogawa, Kazuhiko <br/><br/>
Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Feb 2012 
 - 732-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2010.12.070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Astrocytoma--drug therapy<br/>Brain Neoplasms--drug therapy<br/>Combined Modality Therapy--methods<br/>Dose Fractionation, Radiation<br/>Female<br/>Follow-Up Studies<br/>Glioblastoma--drug therapy<br/>Humans<br/>Hyperbaric Oxygenation--adverse effects<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Nimustine--administration & dosage<br/>Procarbazine--administration & dosage<br/>Radiation Tolerance<br/>Supratentorial Neoplasms--drug therapy<br/>Vincristine--administration & dosage<br/>Young Adult